{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:27:09Z","timestamp":1789010829818,"version":"build-2803163510"},"reference-count":41,"publisher":"China Science Publishing & Media Ltd.","issue":"2","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2024,2,1]]},"DOI":"10.3724\/abbs.2024014","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T22:39:20Z","timestamp":1706222360000},"page":"199-209","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":20,"title":["UBA3 promotes the occurrence and metastasis of                     intrahepatic cholangiocarcinoma through MAPK signaling pathway"],"prefix":"10.3724","volume":"56","author":[{"given":"Huhu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.3390\/cancers14246265","volume":"14","author":"Kupietzky A","year":"2022","unstructured":"Kupietzky A, Ariche A. Surgical aspects of intrahepatic cholangiocarcinoma. Cancers, 2022, 14:","journal-title":"Cancers"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3350\/cmh.2021.0287","volume":"28","author":"Komuta M","year":"2022","unstructured":"Komuta M. Intrahepatic cholangiocarcinoma: tumour heterogeneity and its                         clinical relevance. Clin Mol Hepatol, 2022, 28: 396-407.","journal-title":"Clin Mol Hepatol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3724\/abbs.2022125","volume":"54","author":"Yao X","year":"2022","unstructured":"Yao X, Chen B, Wang M, Zhang S, He B, Shi Z, Deng T. Exploration and validation of a novel ferroptosis-related gene                         signature predicting the prognosis of intrahepatic cholangiocarcinoma. Acta Biochim Biophys                             Sin, 2022, 54: 1376-1385.","journal-title":"Acta Biochim Biophys                             Sin"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.7150\/ijbs.78345","volume":"18","author":"You L","year":"2022","unstructured":"You L, Lin J, Yu Z, Qian Y, Bi Y, Wang F, Zhang L. Nobiletin suppresses cholangiocarcinoma proliferation via                         inhibiting GSK3\u03b2. Int J Biol Sci, 2022, 18: 5698-5712.","journal-title":"Int J Biol Sci"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"996710","DOI":"10.3389\/fonc.2022.996710","volume":"12","author":"Connor AA","year":"2022","unstructured":"Connor AA, Kodali S, Abdelrahim M, Javle MM, Brombosz EW, Ghobrial RM. Intrahepatic cholangiocarcinoma: the role of liver                         transplantation, adjunctive treatments, and prognostic biomarkers. Front Oncol, 2022, 12:","journal-title":"Front Oncol"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.21037\/tgh.2018.08.03","volume":"3","author":"Waisberg DR","year":"2018","unstructured":"Waisberg DR, Pinheiro RS, Nacif LS, Rocha-Santos V, Martino RB, Arantes RM, Ducatti L. Resection for intrahepatic cholangiocellular cancer: new advances. Transl                             Gastroenterol Hepatol, 2018, 3:","journal-title":"Transl                             Gastroenterol Hepatol"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"611738","DOI":"10.3389\/fonc.2021.611738","volume":"11","author":"Zhang H","year":"2021","unstructured":"Zhang H, Chai S, Chen L, Wang Y, Cheng Y, Fang Q, Wu G. MRI features of hepatic sarcomatoid carcinoma different from                         hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Front Oncol, 2021, 11:","journal-title":"Front Oncol"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1073\/pnas.1910765117","volume":"117","author":"Zhang X","year":"2020","unstructured":"Zhang X, Zhang YL, Qiu G, Pian L, Guo L, Cao H, Liu J. Hepatic neddylation targets and stabilizes electron transfer                         flavoproteins to facilitate fatty acid \u03b2-oxidation. Proc Natl Acad Sci                             USA, 2020, 117: 2473-2483.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"667435","DOI":"10.3389\/fcell.2021.667435","volume":"9","author":"Du M","year":"2021","unstructured":"Du M, Peng Z, Gai W, Liu F, Liu W, Chen Y, Li H. The absence of PTEN in breast cancer is a driver of MLN4924                         resistance. Front Cell Dev                             Biol, 2021, 9:","journal-title":"Front Cell Dev                             Biol"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2159-8290.CD-18-0830","volume":"10","author":"Costa C","year":"2020","unstructured":"Costa C, Wang Y, Ly A, Hosono Y, Murchie E, Walmsley CS, Huynh T. PTEN loss mediates clinical cross-resistance to CDK4\/6 and PI3K\u03b1                         inhibitors in breast cancer. Cancer Discov, 2020, 10: 72-85.","journal-title":"Cancer Discov"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1210\/me.2002-0323","volume":"17","author":"Fan M","year":"2003","unstructured":"Fan M, Bigsby RM, Nephew KP. The NEDD8 pathway is required for proteasome-mediated degradation                         of human estrogen receptor (ER)-\u03b1 and essential for the antiproliferative                         activity of ICI 182,780 in ER\u03b1-positive breast cancer cells. Mol Endocrinol, 2003, 17: 356-365.","journal-title":"Mol Endocrinol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1002\/cam4.1578","volume":"7","author":"Yu J","year":"2018","unstructured":"Yu J, Huang WL, Xu QG, Zhang L, Sun SH, Zhou WP, Yang F. Overactivated neddylation pathway in human hepatocellular                         carcinoma. Cancer Med, 2018, 7: 3363-3372.","journal-title":"Cancer Med"},{"key":"CITATION13","doi-asserted-by":"crossref","unstructured":"Xu GW, Toth JI, da Silva SR, Paiva SL, Lukkarila JL, Hurren R,                         Maclean N, et al. Mutations in UBA3 confer resistance to                         the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.                              PLoS One                                                  2014, 9: e93530.","DOI":"10.1371\/journal.pone.0093530"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"BSR20220994","DOI":"10.1042\/BSR20220994","volume":"42","author":"Chen Y","year":"2022","unstructured":"Chen Y, Sun L. Inhibition of NEDD8 NEDDylation induced apoptosis in acute                         myeloid leukemia cells via p53 signaling pathway. Biosci Rep, 2022, 42:","journal-title":"Biosci Rep"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1080\/10428194.2017.1365850","volume":"59","author":"Cao H","year":"2018","unstructured":"Cao H, Xie J, Guo L, Han K, Pei Y, Li X, Qiu G. All- trans retinoic acid induces autophagic                         degradation of ubiquitin-like modifier activating enzyme 3 in acute                         promyelocytic leukemia cells. Leukemia                             Lymphoma, 2018, 59: 1222-1230.","journal-title":"Leukemia                             Lymphoma"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","volume":"85","author":"Ullah R","year":"2022","unstructured":"Ullah R, Yin Q, Snell AH, Wan L. RAF-MEK-ERK pathway in cancer evolution and treatment. Semin                             Cancer Biol, 2022, 85: 123-154.","journal-title":"Semin                             Cancer Biol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3724\/abbs.2023119","volume":"55","author":"Li S","year":"2023","unstructured":"Li S, Wei Y, Sun X, Liu M, Zhu M, Yuan Y, Zhang J. JUNB mediates oxaliplatin resistance via the MAPK signaling                         pathway in gastric cancer by chromatin accessibility and transcriptomic                         analysis. Acta Biochim Biophys                             Sin, 2023, 55: 1784-1796.","journal-title":"Acta Biochim Biophys                             Sin"},{"key":"CITATION18","doi-asserted-by":"crossref","unstructured":"Shimizu T, Kasamatsu A, Yamamoto A, Koike K, Ishige S, Takatori                         H, Sakamoto Y, et al. Annexin A10 in human oral cancer:                         biomarker for tumoral growth via G1\/S transition by targeting MAPK signaling                         pathways.                              PLoS One                                                  2012, 7: e45510.","DOI":"10.1371\/journal.pone.0045510"},{"key":"CITATION19","unstructured":"Sadaria MR, Yu JA, Meng X, Fullerton DA, Reece TB, Weyant MJ.                         Secretory phospholipase A2 mediates human esophageal adenocarcinoma cell                         growth and proliferation via ERK 1\/2 pathway.                              Anticancer                         Res                          2013, 33: 1337\u20131342."},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1182\/blood-2007-12-125856","volume":"112","author":"Kawamura H","year":"2008","unstructured":"Kawamura H, Li X, Goishi K, van Meeteren LA, Jakobsson L, C\u00e9be-Suarez S, Shimizu A. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK                         and endothelial cell organization. Blood, 2008, 112: 3638-3649.","journal-title":"Blood"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"Ritchie ME","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing                         and microarray studies. Nucleic Acids Res, 2015, 43:","journal-title":"Nucleic Acids Res"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"Yu G","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes                         among gene clusters. OMICS, 2012, 16: 284-287.","journal-title":"OMICS"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"Langfelder P","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC BioInf, 2008, 9:","journal-title":"BMC BioInf"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12859-018-2451-4","volume":"19","author":"Sanz H","year":"2018","unstructured":"Sanz H, Valim C, Vegas E, Oller JM, Reverter F. SVM-RFE: selection and visualization of the most relevant                         features through non-linear kernels. BMC BioInf, 2018, 19:","journal-title":"BMC BioInf"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(sici)1097-0258(19970228)16:4<385::aid-sim380>3.0.co;2-3","volume":"16","author":"Tibshirani R","year":"1997","unstructured":"Tibshirani R. The lasso method for variable selection in the cox model. Statist                             Med, 1997, 16: 385-395.","journal-title":"Statist                             Med"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1196\/annals.1310.015","volume":"1020","author":"Izmirlian G","year":"2004","unstructured":"Izmirlian G. Application of the random forest classification algorithm to a                         SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann New York Acad                             Sci, 2004, 1020: 154-174.","journal-title":"Ann New York Acad                             Sci"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"Subramanian A","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A. Gene set enrichment analysis: a knowledge-based approach for                         interpreting genome-wide expression profiles. Proc Natl Acad Sci                             USA, 2005, 102: 15545-15550.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"O111.016253","DOI":"10.1074\/mcp.O111.016253","volume":"11","author":"Jeong JS","year":"2012","unstructured":"Jeong JS, Jiang L, Albino E, Marrero J, Rho HS, Hu J, Hu S. Rapid identification of monospecific monoclonal antibodies using                         a human proteome microarray. Mol Cell                             Proteomics, 2012, 11:","journal-title":"Mol Cell                             Proteomics"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"15084","DOI":"10.1073\/pnas.1521316112","volume":"112","author":"Zhang H","year":"2015","unstructured":"Zhang H, Yang L, Ling J, Czajkowsky DM, Wang JF, Zhang XW, Zhou YM. Systematic identification of arsenic-binding proteins reveals                         that hexokinase-2 is inhibited by arsenic. Proc Natl Acad Sci                             USA, 2015, 112: 15084-15089.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"Eberhardt J","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. Autodock vina 1.2.0: new docking methods, expanded force field,                         and python bindings. J Chem Inf Model, 2021, 61: 3891-3898.","journal-title":"J Chem Inf Model"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"Kim S","year":"2021","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res, 2021, 49: D1388-D1395.","journal-title":"Nucleic Acids Res"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.18632\/oncotarget.2309","volume":"5","author":"Gao Q","year":"2014","unstructured":"Gao Q, Yu GY, Shi JY, Li LH, Zhang WJ, Wang ZC, Yang LX. Neddylation pathway is up-regulated in human intrahepatic                         cholangiocarcinoma and serves as a potential therapeutic target. Oncotarget, 2014, 5: 7820-7832.","journal-title":"Oncotarget"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"Guo YJ","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med, 2020, 19: 1997-2007.","journal-title":"Exp Ther Med"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"1141331","DOI":"10.3389\/fcell.2023.1141331","volume":"11","author":"Zhang H","year":"2023","unstructured":"Zhang H, Zhang Z, Guo T, Chen G, Liu G, Song Q, Li G. Annexin A protein family: focusing on the occurrence, progression                         and treatment of cancer. Front Cell Dev                             Biol, 2023, 11:","journal-title":"Front Cell Dev                             Biol"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/jso.25192","volume":"118","author":"Yamaoka R","year":"2018","unstructured":"Yamaoka R, Ishii T, Kawai T, Yasuchika K, Miyauchi Y, Kojima H, Katayama H. CD90 expression in human intrahepatic cholangiocarcinoma is                         associated with lymph node metastasis and poor prognosis. J Surg Oncol, 2018, 118: 664-674.","journal-title":"J Surg Oncol"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"101991","DOI":"10.1016\/j.clinre.2022.101991","volume":"46","author":"Yang SH","year":"2022","unstructured":"Yang SH, Hu S, Kang Q, Liu LX, Wei Q, Song ZM, Chen YH. EIF5A2 promotes proliferation and invasion of intrahepatic                         cholangiocarcinoma cells. Clin Res                             Hepatol Gastroenterol, 2022, 46:","journal-title":"Clin Res                             Hepatol Gastroenterol"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"104691","DOI":"10.1016\/j.yexmp.2021.104691","volume":"123","author":"Shu B","year":"2021","unstructured":"Shu B, Zhou Y, Liang Q, He C, Li F. HSPB8 promoted intrahepatic cholangiocarcinoma progression by                         enhancing epithelial-mesenchymal transition and autophagy. Exp Mol Pathol, 2021, 123:","journal-title":"Exp Mol Pathol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"Kelley RK","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol, 2020, 72: 353-363.","journal-title":"J Hepatol"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/jamaoncol.2021.3836","volume":"7","author":"Zhu AX","year":"2021","unstructured":"Zhu AX, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, Cleary JM. Final overall survival efficacy results of ivosidenib for                         patients with advanced cholangiocarcinoma with IDH1                         mutation. JAMA Oncol, 2021, 7: 1669-1677.","journal-title":"JAMA Oncol"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1080\/07391102.2013.804436","volume":"32","author":"Verma S","year":"2014","unstructured":"Verma S, Singh A, Mishra A. Molecular dynamics investigation on the poor sensitivity of A171T                         mutant NEDD8-activating enzyme (NAE) for MLN4924. J Biomol                             Structure Dyn, 2014, 32: 1064-1073.","journal-title":"J Biomol                             Structure Dyn"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1084\/jem.20092759","volume":"207","author":"Flomerfelt FA","year":"2010","unstructured":"Flomerfelt FA, El Kassar N, Gurunathan C, Chua KS, League SC, Schmitz S, Gershon TR. Tbata modulates thymic stromal cell                         proliferation and thymus function. J Exp Med, 2010, 207: 2521-2532.","journal-title":"J Exp Med"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/4A084148EC9C4E58A81EB49774CD4AA7","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024014","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/4A084148EC9C4E58A81EB49774CD4AA7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T01:58:43Z","timestamp":1708999123000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,31]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2024014","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,31]]}}}